Innovative therapeutics

Investors

NASDAQBMRN
FormDescriptionDateFormat
CT ORDERConfidential treatment orderDec 8, 2015View HTMLDownload DOCDownload PDFDownload XLS
CT ORDERConfidential treatment orderDec 8, 2015View HTMLDownload DOCDownload PDFDownload XLS
SC 13G/AAmendment to a previously filed SC 13GSep 10, 2015View HTMLDownload DOCDownload PDFDownload XLS
SC 13G/AAmendment to a previously filed SC 13GJun 5, 2015View HTMLDownload DOCDownload PDFDownload XLS
SC 13G/AAmendment to a previously filed SC 13GFeb 13, 2015View HTMLDownload DOCDownload PDFDownload XLS
SC 13G/AAmendment to a previously filed SC 13GFeb 13, 2015View HTMLDownload DOCDownload PDFDownload XLS
SC 13G/AAmendment to a previously filed SC 13GFeb 13, 2015View HTMLDownload DOCDownload PDFDownload XLS
SC 13G/AAmendment to a previously filed SC 13GFeb 10, 2015View HTMLDownload DOCDownload PDFDownload XLS
SC 13G/AAmendment to a previously filed SC 13GFeb 9, 2015View HTMLDownload DOCDownload PDFDownload XLS
SC 13G/AAmendment to a previously filed SC 13GFeb 6, 2015View HTMLDownload DOCDownload PDFDownload XLS
SC 13G/AAmendment to a previously filed SC 13GFeb 2, 2015View HTMLDownload DOCDownload PDFDownload XLS
SC 13D/AAmendment to a SC 13D filingFeb 2, 2015View HTMLDownload DOCDownload PDFDownload XLS
SC 13DFiling by person(s) reporting owned shares of common stock in a public company >5%Jan 26, 2015View HTMLDownload DOCDownload PDFDownload XLS
EFFECTNotice from the SEC of registration effectivenessJan 22, 2015View HTMLDownload DOCDownload PDFDownload XLS

BioMarin

Diseases

Lysosomal Storage Disorders (MPS I, MPS IVA, MPS VI, CLN2 disease) PKU, LEMS

Products

Palynziq™
Brineura™
Vimizim®
Kuvan®
Naglazyme®
Aldurazyme®
Firdapse®

Patient/Physician Support Contact Information

BioMarin RareConnections
Tel: 866.906.6100
Fax: 888.863.3361
E-mail: support@biomarin-rareconnections.com

Global Medical Information

Contact Global Medical Information